Search

everythinglearnresearchcommunity

for

Search:↓

Glass ceiling syndrome is linked to stress-related hair loss in female healthcare workers.

The supplement improved hair health and reduced shedding in people with telogen effluvium.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

COVID-19 infection may cause hair loss a few months after recovery.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.

Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

The poem reflects on hair loss, health concerns, and introspection.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Oral minoxidil effectively reduces hair shedding in women with chronic telogen effluvium.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Low zinc levels are strongly linked to hair loss in adult premenopausal women.